Results 121 to 130 of about 39,777 (194)

Relapse and Emergent Resistance With Novel Short-Course Regimens for Multidrug-Resistant Tuberculosis, United States, 2022-2024. [PDF]

Open Forum Infect Dis
Liang R, Brust JCM, Reed C, Escuyer V, Armstrong DT, Parrish N, Valois P, Rowlinson MC, Marinova-Petkova A, Bisson GP, Labuda SM, Colon-Semidey A, Haley CA, Ashkin D, Peloquin CA, Lardizabal A, Patrawalla A, Cuenca A, Haas MK, Brostrom R, Mbakwem C, Schechter MC, Ray SM, Cummins J, Cahill B, Arn K, Chen LL, Wilson JW, Goswami ND.   +28 more
europepmc   +1 more source

Multidrug-Resistant Tuberculosis in Rural Eastern Cape, South Africa: Clinical, Bacteriological, and Programmatic Predictors of Poor Treatment Outcomes. [PDF]

Microorganisms
Cebisa M, Dlatu N, Hosu MC, Apalata T, Faye LM.   +4 more
europepmc   +1 more source

Spatial distribution and clustering of multidrug-resistant tuberculosis in Uganda: a nationwide ecological study (2014-2023)

Akello SR, Alunyo JP, Matovu JK, Emetu J, Oposhia J, Ssanyu GN, Bogere MN, Birungi P, Madenje M, Okalebo BC, Okiror W, Paasi G, Nsubuga S, Aujo D, Okibure A, Mukunya D, Olupot-Olupot P.   +16 more
europepmc   +1 more source

Multidrug-resistant tuberculosis (MDR-TB) in people living with HIV: Clinical issues, therapeutic challenges and perspectives in sub-Saharan Africa. A narrative review. [PDF]

J Clin Tuberc Other Mycobact Dis
Tague C.
europepmc   +1 more source

Quality of life scores using SF-12 and SF-36v2 questionnaires for patients with multidrug-resistant tuberculosis in Vietnam. [PDF]

Health Qual Life Outcomes
Ha NTL, Hoa NB, Yapa M, Anh NT, Li Q, Dang VH, Fox GJ, Dat VQ.   +7 more
europepmc   +1 more source

Spatial autocorrelation and hotspot dynamics of multidrug-resistant tuberculosis in Uganda: a district-level LISA analysis

Akello SR, Alunyo JP, Matovu JK, Emetu J, Mugasha E, Paasi G, Okibure A, Mukunya D, Olupot-Olupot P.   +8 more
europepmc   +1 more source

Performance of active drug safety monitoring and management for pharmacovigilance strengthening in Ethiopia, experience from a multidrug-resistant tuberculosis management program: a cross-sectional study. [PDF]

BMJ Open
Achalu DL, Meshesha SG, Kiltu AB, Wendimu DE, Tegegne NA, Alemu A, Tiemersma EW, Cobelens F, Teferi M.   +8 more
europepmc   +1 more source

Gender disparities in multidrug-resistant tuberculosis notifications in Uganda: evidence from national surveillance data, 2014-2023

Akello SR, Alunyo JP, Matovu JK, Mugasha E, Emetu J, Paasi G, Okibure A, Mukunya D, Olupot-Olupot P.   +8 more
europepmc   +1 more source

Treatment outcomes and long-term relapse-free survival after multidrug-resistant tuberculosis treatment in Latvia: a retrospective national cohort study. [PDF]

Lancet Reg Health Eur
Meier SC, Kukša L, Ķauķe S, Riekstina V, Biraua E, Jain N, Lange C, Brehm TT.   +7 more
europepmc   +1 more source

Population-based study of pharmacogenetics and pharmacokinetics in Southern African patients with multidrug-resistant tuberculosis (PoPG): a protocol for the Namibian cohort. [PDF]

BMJ Open
Boois L, Ekandjo H, Shavuka O, Nepolo E, Ndong Sima CA, Oelofse C, Uren C, Petersen DC, Möller M, Wijk M, Kellermann T, Decloedt E, McIlleron H, Denti P, Claassens MM.   +14 more
europepmc   +1 more source